Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.

• Váldodahkkit: Claude Flamand (Dahkki), Christelle Alves Sarmento (Dahkki), Antoine Enfissi (Dahkki), Sarah Bailly (Dahkki), Emmanuel Beillard (Dahkki), Mélanie Gaillet (Dahkki), Céline Michaud (Dahkki), Véronique Servas (Dahkki), Nathalie Clement (Dahkki), Anaïs Perilhou (Dahkki), Thierry Carage (Dahkki), Didier Musso (Dahkki), Jean-François Carod (Dahkki), Stéphanie Eustache (Dahkki), Céline Tourbillon (Dahkki), Elodie Boizon (Dahkki), Samantha James (Dahkki), Félix Djossou (Dahkki), Henrik Salje (Dahkki), Simon Cauchemez (Dahkki), Dominique Rousset (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Public Library of Science (PLoS), 2021-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

<h4>Background</h4>While Latin America has been heavily affected by the pandemic, only a few seroprevalence studies have been conducted there during the first epidemic wave in the first half of 2020.<h4>Methodology/principal findings</h4>A cross-sectional survey was performed...